Found 19 matching trials
Relapsed/Refractory Large B-cell Lymphoma With NT-I7 Post-CD19 CAR T-cell Therapy PHASE1 This is a multicenter Phase 1b study evaluating the safety, tolerability, a...
Show More Learn More & Join Trial
A Trial of NT-I7 in COVID-19 (SPESELPIS) PHASE1 The main purposes of this study is to determine the following in participan...
Show More Learn More & Join Trial
Safety and Preliminary Efficacy Study of GX-I7 in Patients With COVID-19 PHASE1 This study is a phase 1b clinical trial to investigate the safety and preli...
Show More Location
Borame Medical Center
Learn More & Join Trial
NT-I7 (Efineptakin Alfa), a Long-acting Human IL-7, Post-Axicabtagene Ciloleucel or Post-Lisocabtagene Maraleucel in Subjects With Relapsed/Refractory Large B-cell Lymphoma PHASE1 Diffuse large B-cell lymphoma is the most commonly occurring subtype of non...
Show More Location
Washington University School of Medicine
Learn More & Join Trial
NT-I7 in Combination With Atezolizumab in Previously Untreated, PD-L1-expressing, Locally Advanced or Metastatic NSCLC PHASE2 This is a multicenter, open-label, single-arm Phase II study to evaluate an...
Show More Location
University of South Alabama
Learn More & Join Trial
NT-I7 for the Treatment of Recurrent Squamous Cell Carcinoma of Head and Neck Undergoing Surgery PHASE1 This phase I trial evaluates the side effects of NT-I7 in treating patients...
Show More Location
University of California San Francisco
Learn More & Join Trial
NT-I7 for Kaposi Sarcoma in Patients With or Without HIV PHASE1 This phase I trial studies the best dose and effects of NT-I7 in treating K...
Show More Location
Zuckerberg San Francisco General Hospital
Learn More & Join Trial
Vaccine Response With NT-I7 PHASE1 Background:
People with cancer, and especially older people, have a weaken...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
A Study to Evaluate the Safety and Efficacy of GX-I7 in Elderly Patients With Asymptomatic or Mild Symptoms of COVID-19 PHASE2 This is a Phase 2 prospective, randomized, placebo-controlled, double-blind...
Show More Location
Mitra Keluarga Kelapa Gading
Learn More & Join Trial
Recombinant Human IL-7 (NT-I7) in Relapsed/Refractory Multiple Myeloma Following BCMA CAR-T Therapy (Cilta-cel) PHASE1 CAR-T cell therapy is an emerging treatment modality in relapsed and refrac...
Show More Location
Washington University School of Medicine
Learn More & Join Trial